NFKB1 and COVID-19: In comparison to the published paper by Simon J. L. Petitjean49, which demonstrated the effects of Danshen extracts against COVID-19 by blocking the binding of SARS-CoV-2 to the ACE2 receptor and alleviating the inflammatory response from leukocytes by interfering with NF-κB signaling, our study fills the gap by investigating multiple targets and pathways in a comprehensive and systematic manner.